Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation

Live In-Person Event | Boston, MA

February 7-11, 2022

About this Course

49th Annual Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation

Tufts CSDD’s five-day Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation will resume in 2022 as a live in-person event in Boston, Massachusetts (venue to be determined). This highly acclaimed program provides advanced instruction in practical and technical problem-solving in the areas of clinical pharmacology, drug development & clinical trial strategies, biopharmaceutical development, drug safety, and new drug regulation. During an exclusive Q&A session with a senior FDA official, participants will receive first-hand insights into FDA priorities and operations and will emerge with a better understanding of the regulatory process. For more information we have provided an agenda and a detailed program description from our most recent live course in 2020.

Earn a Digital Course Completion Badge!

  • Showcase the knowledge and skills you acquired from the program.
  • Share your learning achievements with clients, employers, and colleagues on online platforms and social media networks like LinkedIn, Facebook and Twitter.

Who Should Attend?

  • Physicians, pharmacists, marketing executives, clinical researchers, nurses, analysts, investors, and any professional working with or in the research-based drug industry

  • Professionals looking to begin work in the pharma or biotech sectors and seeking comprehensive and foundational industry knowledge and training

  • Individuals employed by regulatory agencies, academic institutions, outsourcing providers, consultancy firms, niche service providers, and other organizations involved in the research, development, and regulation of pharmaceutical products

Course Goals:

The Tufts CSDD Postgraduate Course is designed to provide students with a broad and comprehensive understanding of issues related to the development and regulation of drugs, biologics, vaccines, devices, and in vitro diagnostics. Lectures focus on basic drug development topics — such as translational medicine, clinical pharmacology, epidemiology, drug regulation, and adverse drug event reporting — as well as broader topics such as pharmacoeconomics, drug-device combinations, biosimilars, working with investigative sites, and drug marketing.

Educational Objectives

  • Clinical Pharmacology: Integrate the relevant pharmacology, pharmacokinetics, and statistics related to drug development and the nature of evidence required for proof of efficacy and safety.

  • Drug Development and Clinical Trials: Using a case-study approach, identify and solve practical, theoretical, and technical problems in human drug studies and analyze an experimental design for a new drug candidate.

  • Regulation: Evaluate the science, laws, and regulations pertaining to the development and review of new drug products in the U.S., Europe, Japan and other pharmaceutical markets.

Tufts CSDD Postgraduate Course COVID-19 Safety Assurances

  • Tufts CSDD is closely following all coronavirus-related news and updates before and during the event and will convey updates to all course registrants and faculty.
  • All registrants and faculty must submit proof of vaccination for admittance into the course.
  • All documents pertaining to the course will be provided electronically.
  • Tufts CSDD will limit the attendance of guests to ensure safe social distancing.
  • We will have ample supplies such as hand sanitizer, soap and face masks available. Surfaces and objects used frequently will be disinfected on a regular basis.
  • All food/ and drink options will be presented as individual servings, with available space to ensure everyone can maintain safe social distancing.
"Taking the Tufts course was a tremendously beneficial experience for me. I'm so grateful to have learned so much and met such wonderful colleagues. You created a fantastic roster of speakers and presentations." Past Participant
“Being new to the industry I appreciated that all the presentations provided excellent background information before examining each topic in more depth.” Past Participant
“The Regulation overview for U.S., E.U., Japan, and China were extremely useful. The presentation captured essential knowledge for those areas.” Past Participant
“The mock drug groups activity was very helpful because it brought together a handful of people from different backgrounds and professions. It encouraged team-building and communication — two things that are very much needed in the work field.” Past Participant

Early Bird

Regular Rate

(Ends 10/31/21)


Early Bird

Sponsor Rate

(Ends 10/31/21)



(No end date)


*To inquire about group rates, please email


Have any questions? Enter your information below to get in touch with our enrollment team. 

Ready to enroll?